Aerie Pharmaceuticals, Inc.

符号: AERI

NASDAQ

15.25

USD

今天的市场价格

-9.4457
市盈率
0.2147
PEG比率
753.62M
MRK市值
0.00%
DIV收益率

Aerie Pharmaceuticals, Inc. (AERI) 财务报表

Q: 什么是 Aerie Pharmaceuticals, Inc. (AERI) 总资产是多少？

Aerie Pharmaceuticals, Inc. (AERI) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Aerie Pharmaceuticals, Inc. (AERI). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Aerie Pharmaceuticals, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	TTM	2020	2018	2016	2014	2012
balance-sheet.row.cash-and-short-term-investments	691.88	139.8	240.4	309.2	202.8	249.7	233.7	136.6	139.9	69.6	2.9	15.1
balance-sheet.row.short-term-investments	504.72	102.6	88.8	165.3	0	52.1	35.7	45.5	54.3	0	0	0
balance-sheet.row.net-receivables	364.41	158.8	56	38.4	2.7	0	0	0	0	0	0	0
balance-sheet.row.inventory	174.37	40.4	27.1	21.1	10.1	0	0	0	0	0	0	0
balance-sheet.row.other-current-assets	56.18	16.6	8.3	7.7	4.5	4.5	4	1.9	1.1	0.6	0.1	0.1
balance-sheet.row.total-current-assets	1286.84	355.6	331.8	376.3	220.2	254.1	237.7	138.4	141	70.3	3	15.2
balance-sheet.row.property-plant-equipment-net	290.73	74.1	68.3	58.1	60.5	31.9	7.9	3.8	0.2	0.1	0.1	0.2
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	3.98	0	0	0	0	0	0	13.8	18.3	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	6.32	1.6	1.9	18.1	4.3	4.2	2.7	3.1	1.5	0.1	0	0
balance-sheet.row.total-non-current-assets	301.03	75.7	70.3	76.3	64.9	36.1	10.6	20.7	20	0.2	0.2	0.3
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1587.87	431.4	402	452.6	285	290.3	248.3	159.1	161.1	70.5	3.2	15.5
balance-sheet.row.account-payables	34.5	8.3	8.8	12.8	12.4	6.2	5.6	1.6	2.1	1.4	0.2	0.2
balance-sheet.row.short-term-debt	18.45	4.4	4.9	5.5	0	0	0	0	0	0	2.3	0
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	1.7	0	0	0	0
balance-sheet.row.long-term-debt-total	1253.65	256.3	210.4	188.7	0	123.8	123.5	123.2	124.2	0	0	0
Deferred Revenue Non Current	275.63	64.3	50.9	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	164.69	48	39.9	65.4	38.4	18.9	13.8	15.5	6.8	2	1.3	2.5
balance-sheet.row.total-non-current-liabilities	1542.75	323.7	273.6	202	6.5	129.5	123.5	123.2	124.2	0	2.5	1.1
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	101.17	26.1	15.1	17.6	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	2036.03	448.7	378.1	285.7	57.2	154.7	142.9	140.4	133	3.5	6.2	3.8
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	70.5	60.9	60.3
balance-sheet.row.common-stock	0.19	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-4645	-1153.9	-1079.1	-896	-696.4	-461.7	-316.6	-217.6	-143.2	-95.1	-63.9	-48.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	-2.15	-0.1	-0.1	-0.1	0	0	-0.1	-0.2	-0.1	-0.9	-0.9	-0.7
balance-sheet.row.other-total-stockholders-equity	4198.8	1136.7	1103.1	1063	924.2	597.3	422	236.5	171.3	92.5	0.9	0.9
balance-sheet.row.total-stockholders-equity	-448.16	-17.3	24	166.9	227.8	135.6	105.3	18.8	28	67	-3	11.7
balance-sheet.row.total-liabilities-and-stockholders-equity	1587.87	431.4	402	452.6	285	290.3	248.3	159.1	161.1	70.5	3.2	15.5
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	-448.16	-17.3	24	166.9	227.8	135.6	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	1587.87	-	-	-	-	-	-	-	-	-	-	-
Total Investments	508.71	102.6	88.8	165.3	0	52.1	35.7	59.3	72.6	0	0	0
balance-sheet.row.total-debt	1272.1	260.6	215.3	194.2	0	123.8	123.5	123.2	124.2	0	2.3	0
balance-sheet.row.net-debt	1084.93	223.5	63.7	50.2	-202.8	-73.7	-74.4	32.2	38.6	-69.6	-0.6	-15.1

现金流量表

在 Aerie Pharmaceuticals, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2020	2018	2016	2014	2012
cash-flows.row.net-income	-36.55	-74.8	-183.1	-199.6	-232.6	-145.1	-99.1	-74.4	-48.1	-31.1	-15	-13
cash-flows.row.depreciation-and-amortization	20.17	37.5	34.2	18.1	2.4	1.4	1	0.3	0.1	0.1	0.1	0.1
cash-flows.row.deferred-income-tax	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	18.4	29.5	40.1	45.1	38.7	26.1	16.8	12.9	9.2	2.9	0.4	0.3
cash-flows.row.change-in-working-capital	5.69	-92.6	44.9	-24	13.4	-1.3	0.6	4.5	4.7	2.1	-1.2	1.8
cash-flows.row.account-receivables	-9.31	-12.8	-17.7	-35.6	-2.7	0	0	0	0	0	0	0
cash-flows.row.inventory	-15.16	-12.1	-5.2	-10.3	-9.7	0	0	0	0	0	0	0
cash-flows.row.account-payables	-7.51	21.6	16.9	-270.8	26.6	0.9	2.5	5.4	4.8	2	-1.3	1.7
cash-flows.row.other-working-capital	37.68	-89.2	50.9	292.7	-0.8	-2.2	-1.9	-0.8	-0.2	0.1	0	0.1
cash-flows.row.other-non-cash-items	-0.53	1.2	-0.7	9.9	25.4	25.7	0.8	0.9	0.5	9.7	0.7	-1.3
cash-flows.row.net-cash-provided-by-operating-activities	7.17	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-4.53	-3.3	-3.1	-10	-31.3	-16	-5.1	-3.3	-0.2	-0.1	-0.1	0
cash-flows.row.acquisitions-net	0	0	0	0	0	-10.5	5.6	3.9	0.6	0	0	0
cash-flows.row.purchases-of-investments	-165.66	-132.4	-116.6	-165.5	-56.2	-104.5	-35.2	-46.9	-95.4	0	0	0
cash-flows.row.sales-maturities-of-investments	151.88	117.5	192.9	0	108.3	88.2	58.3	59.5	22.2	0	0	0
cash-flows.row.other-investing-activites	0	0	0	-7.8	0	0	-5.6	-3.9	-0.6	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-18.3	-18.2	73.2	-183.2	20.8	-42.8	18.1	9.4	-73.3	-0.1	-0.1	0
cash-flows.row.debt-repayment	0	0	-8.3	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-issued	2.42	3	-0.9	0.7	136	134.2	168.5	50.5	0	71.9	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	0	0	0	0	0	0	0	0	-0.1	0
cash-flows.row.other-financing-activites	0.96	0	8.3	274.1	1.1	1.4	0.1	1.4	123	11.4	3	23.8
cash-flows.row.net-cash-used-provided-by-financing-activities	3.38	3	-0.9	274.8	137	135.6	168.6	51.8	123	83.2	2.9	23.8
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-7.75	-114.4	7.6	-58.9	5.2	-0.4	106.9	5.5	15.9	66.7	-12.1	11.8
cash-flows.row.cash-at-end-of-period	187.16	37.2	151.6	143.9	202.8	197.6	197.9	91.1	85.6	69.6	2.9	15.1
cash-flows.row.cash-at-beginning-of-period	194.92	151.6	143.9	202.8	197.6	197.9	91.1	85.6	69.6	2.9	15.1	3.3
cash-flows.row.operating-cash-flow	7.17	-99.2	-64.7	-150.4	-152.6	-93.2	-79.8	-55.7	-33.7	-16.4	-15	-12
cash-flows.row.capital-expenditure	-4.53	-3.3	-3.1	-10	-31.3	-16	-5.1	-3.3	-0.2	-0.1	-0.1	0
cash-flows.row.free-cash-flow	2.64	-102.4	-67.8	-160.4	-183.9	-109.2	-84.9	-59	-33.9	-16.5	-15	-12

利润表行

Aerie Pharmaceuticals, Inc. 的收入与上期相比变化了 NaN%。据报告, AERI 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	TTM	2020	2018	2016	2014	2012
income-statement-row.row.total-revenue	213.94	194.1	83.1	69.9	24.2	0	0	0	0	0	0	0
income-statement-row.row.cost-of-revenue	23.52	26.8	25.3	4.8	0.6	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	190.42	167.3	57.8	65.1	23.5	0	0	0	0	0	0	0
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	87.57	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	0	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	0	0	2.3	22.8	26.5	0	0	0	0	0	0	0
income-statement-row.row.operating-expenses	217.13	213.6	213.5	252.5	233.3	145.7	96.9	75.1	50	22.2	14.3	14.2
income-statement-row.row.cost-and-expenses	240.65	240.5	238.8	257.4	233.9	145.7	96.9	75.1	50	22.2	14.3	14.2
income-statement-row.row.interest-income	0.88	0.1	2	3	3.4	1.8	0	0	0	0	0	0
income-statement-row.row.interest-expense	11.99	28.9	26.5	15.3	2.5	2.4	2.5	2.5	0.6	3.8	0.1	0.1
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-11.99	-28.9	-22.2	-12.2	-22.8	-1.2	-2	0.9	1.8	-9	-0.7	1.2
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	0	0	2.3	22.8	26.5	0	0	0	0	0	0	0
income-statement-row.row.total-operating-expenses	-11.99	-28.9	-22.2	-12.2	-22.8	-1.2	-2	0.9	1.8	-9	-0.7	1.2
income-statement-row.row.interest-expense	11.99	28.9	26.5	15.3	2.5	2.4	2.5	2.5	0.6	3.8	0.1	0.1
income-statement-row.row.depreciation-and-amortization	20.17	37.5	34.2	18.1	2.4	1.4	1	0.3	0.1	0.1	0.1	0.1
income-statement-row.row.ebitda-caps	-3.07	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-23.24	-45.3	-155.7	-187.5	-209.7	-145.7	-96.9	-75.1	-50	-22.2	-14.3	-14.2
income-statement-row.row.income-before-tax	-35.23	-74.2	-177.9	-199.7	-232.6	-146.9	-98.9	-74.2	-48.1	-31.1	-15	-13
income-statement-row.row.income-tax-expense	1.32	0.6	5.2	-0.1	0	-1.8	0.2	0.1	2.5	-5.2	-0.6	1.4
income-statement-row.row.net-income	-36.55	-74.8	-183.1	-199.6	-232.6	-145.1	-99.1	-74.4	-48.1	-31.1	-15	-13